 |
| Are Glaxo up for the challenge? |
As mentioned in a previous post, I've been trawling through thousands of clinical trials during the past few months and one thing that struck me was Glaxo's inability to run any sort of trial that proves their antidepressant, Seroxat [known as Paxil in US, Aropax in Aus] is not addictive.
Surely the world's second biggest pharmaceutical company would move Heaven and earth to prove this point, a clinical trial showing Seroxat caused no withdrawal problem would be the ace up their sleeve when faced with litigation.
Glaxo have settled over 3,000 withdrawal cases in the US, they have never used any withdrawal clinical trial as a defence...because they have never carried out any. Even if they have, they more than likely pulled the trial because signs were not favourable.
So the challenge is simple.
Would GlaxoSmithKline be prepared to conduct a challenge/re-challenge clinical trial?
Subjects can be given Seroxat, taken off it, then started on it again.
Simple really but not so for Glaxo.
"There is no proof that the drug [Seroxat] does these things and because of that there is no reason to carry out trials that might decide it one way or the other." [1]
Yeh right, instead they can settle with over 3,000 claimants and seal the evidence as part of that settlement.
The proof, as they say, is in the pudding.
[1] The evidence, however, is clear...the Seroxat scandal Pg 53
Fid
ORDER THE PAPERBACK 'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman US and CANADA HERE
OR UK FROM CHIPMUNKA PUBLISHING
AUSTRALIAN ORDERS HERE
No comments: